United voices at the International Pediatric Neuro-Oncology Symposium in Porto Alegre, Brazil: "In many places around the world, medulloblastoma is still being diagnosed as it was nearly 100 years ago," said Dr. Michael Taylor, who opened the event.
"We have to develop better treatments for medulloblastoma," said Dr. Vijay Ramaswamy. All the physicians and researchers then heard the testimony of journalist Daniel Scola, who survived medulloblastoma but still faces the side effects.
The MBI was also present — MBI founder Fernando Goldsztein recalled the question he asked Dr. Roger Packer of Children's National Hospital in 2021: What can we do to advance science? The answer came through philanthropy, which enabled the creation of the Cure Group 4 Consortium, coordinated by Dr. Packer, and including Dr. Taylor and Dr. Ramaswamy's labs. Since then, MBI has built a supportive community that brings together people like Scola and everyone who understands that philanthropy can change the landscape of science.
